Rossari Biotech Ltd

Rossari Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Rossari Biotech Ltd

₹ 857 -2.19%
11 Dec 2:45 p.m.
rossari.com BSE: 543213 NSE: ROSSARI
About

Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. [1]

Their 3 main product categories are [2]:
- Home, personal care, and performance chemicals
- Textile specialty chemical
- Animal health and nutrition

The company has two R&D facilities, one at Silvassa manufacturing facility and a research lab at IIT Bombay. [3]

Key Points

Company Overview
Rossari Biotech is a Specialty-Chemicals manufacturer offering solutions for Home, Personal Care and Performance chemicals (HPPC), Textile specialty chemicals (TSC) and Animal Health and Nutrition (AHN). It offers a total of 4220+ products catering to an array of applications across FMCG, Home care, Industrial Cleaning, Personal Care, Textile, Performance Chemicals, Animal Health and Nutrition and Pet Care businesses. [1] [2]

Website BSE NSE
  • Market Cap ₹ 4,750 Cr.
  • Current Price ₹ 857
  • High / Low ₹ 973 / 657
  • Stock P/E 34.2
  • Book Value ₹ 202
  • Dividend Yield 0.06 %
  • ROCE 18.1 %
  • ROE 13.2 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Company has a low return on equity of 13.6% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE Commodities BSE SmallCap Nifty Total Market BSE Allcap Nifty Microcap 250

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
385 428 439 435 425 389 406 411 483 464 473 490 498
339 381 387 377 369 335 352 353 420 400 409 425 432
Operating Profit 46 48 52 58 57 54 55 58 64 64 64 65 66
OPM % 12% 11% 12% 13% 13% 14% 13% 14% 13% 14% 13% 13% 13%
2 6 3 1 1 1 3 2 1 4 1 1 1
Interest 2 5 5 5 8 5 4 6 5 4 3 4 4
Depreciation 10 16 17 15 16 16 16 14 15 15 16 15 15
Profit before tax 36 33 34 39 34 35 37 39 45 48 46 47 48
Tax % 27% 30% 30% 26% 29% 26% 22% 26% 26% 28% 25% 26% 27%
26 23 24 29 24 26 29 29 33 34 34 35 35
EPS in Rs 4.76 4.14 4.37 5.21 4.34 4.66 5.25 5.30 5.97 6.23 6.18 6.32 6.39
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
516 600 709 1,483 1,656 1,831 1,924
438 495 586 1,299 1,433 1,581 1,666
Operating Profit 78 105 124 184 223 250 258
OPM % 15% 17% 17% 12% 13% 14% 13%
1 4 9 13 6 8 6
Interest 3 4 3 13 22 19 14
Depreciation 12 17 23 48 63 60 62
Profit before tax 63 88 107 136 144 178 188
Tax % 28% 26% 25% 28% 26% 26%
46 65 80 98 107 131 139
EPS in Rs 103.82 12.86 15.45 17.74 19.45 23.66 25.12
Dividend Payout % 0% 4% 3% 3% 3% 2%
Compounded Sales Growth
10 Years: %
5 Years: 29%
3 Years: 37%
TTM: 14%
Compounded Profit Growth
10 Years: %
5 Years: 23%
3 Years: 18%
TTM: 19%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -14%
1 Year: 7%
Return on Equity
10 Years: %
5 Years: 16%
3 Years: 14%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 4 10 10 11 11 11 11
Reserves 119 277 398 794 904 1,037 1,107
8 67 0 8 74 119 161
118 118 152 442 375 401 433
Total Liabilities 250 471 561 1,255 1,364 1,567 1,711
74 94 181 607 585 578 597
CWIP 3 22 0 1 16 47 98
Investments 0 18 0 36 51 63 53
173 338 379 611 712 880 963
Total Assets 250 471 561 1,255 1,364 1,567 1,711

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
71 57 48 29 152 43
-37 -190 -37 -299 -181 -103
-29 157 -25 292 61 16
Net Cash Flow 5 23 -14 22 32 -44

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 61 57 74 75 78 85
Inventory Days 59 57 75 63 59 80
Days Payable 114 95 104 61 56 62
Cash Conversion Cycle 6 19 46 76 80 103
Working Capital Days 25 39 60 64 57 85
ROCE % 38% 29% 24% 18% 18%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
68.56% 68.56% 68.56% 68.46% 68.44% 68.44% 68.44% 68.35% 68.34% 68.32% 68.32% 68.27%
9.13% 9.03% 8.51% 8.84% 8.63% 7.46% 6.12% 5.74% 4.14% 4.02% 3.83% 3.74%
12.77% 12.29% 13.02% 14.15% 14.08% 15.09% 17.71% 17.68% 18.06% 17.74% 16.87% 17.34%
9.54% 10.12% 9.91% 8.55% 8.85% 9.01% 7.73% 8.23% 9.45% 9.90% 10.98% 10.64%
No. of Shareholders 76,49492,09998,56595,66497,08196,63495,37195,2001,00,42398,8591,00,47597,188

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls